Tags: Drug.
Sirukumab (CNTO 136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.Sirukumab is currently under development by Johnson & Johnson’s subsidiary Centocor.
Loading...
This page contains content from the copyrighted Wikipedia article "Sirukumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.